Topical 4% nicotinamide vs. 1% clindamycin in moderate inflammatory acne vulgaris

International Journal of Dermatology

Volumn 52, Issue 8, 2013, Pages 999-1004

  Khodaeiani, Effat ^a   Fouladi, Rohollah Fadaei ^b   Amirnia, Mehdi ^a   Saeidi, Majid ^c   Karimi, Elham Razagh ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; NICOTINAMIDE;

ACNE VULGARIS; ADULT; ARTICLE; COMPARATIVE EFFECTIVENESS; CONTACT DERMATITIS; CONTROLLED STUDY; COOK ACNE GRADE; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EXUDATIVE EPIDERMITIS; FACE; FEMALE; GEL; HUMAN; MAJOR CLINICAL STUDY; MALE; OILY SKIN; OUTCOME ASSESSMENT; PAPULE; PUSTULE; RANDOMIZED CONTROLLED TRIAL; SKIN BURNING SENSATION; SKIN PRURITUS; SKIN SURFACE; TOPICAL TREATMENT;

ACNE VULGARIS; ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CLINDAMYCIN; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; NIACINAMIDE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VITAMIN B COMPLEX; YOUNG ADULT;

EID: 84880698201     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/ijd.12002     Document Type: Article

References (32)

1. Hsu P, Litman GI, Brodell RT. Overview of the treatment of acne vulgaris with topical retinoids. Postgrad Med 2011; 123: 153-1561.
2. Kraft J, Freiman A. Management of acne. CMAJ 2011; 183: E430-435.
3. Smith EV, Grindlay DJ, Williams HC. What's new in acne? An analysis of systematic reviews published in 2009-2010. Clin Exp Dermatol 2011; 36: 119-122.
4. Khodaeiani E, Fouladi RF, Yousefi N, et al. Efficacy of 2% metronidazole gel in moderate acne vulgaris. Indian J Dermatol 2012; 57: 279-281.
5. Imahiyerobo-Ip JI, Dinulos JG. Changing the topography of acne with topical medications. Curr Opin Pediatr 2011; 23: 121-125.
6. Babaeinejad S, Khodaeiani E, Fouladi RF. Comparison of therapeutic effects of oral doxycycline and azithromycin in patients with moderate acne vulgaris: What is the role of age? J Dermatolog Treat 2011; 22: 206-210.
7. Ingram JR, Grindlay DJ, Williams HC. Management of acne vulgaris: an evidence-based update. Clin Exp Dermatol 2010; 35: 351-354.
8. Cook D, Krassas G, Huang T. Acne - best practice management. Aust Fam Physician 2010; 39: 656-660.
9. Ramos-e-Silva M, Carneiro SC. Acne vulgaris: review and guidelines. Dermatol Nurs 2009; 21: 63-68.
10. Burns DA, Breathnach SM, Cox N, et al. Rook's Textbook of Dermatology. Singapore: Wiley-Blackwell 2004.
11. Shalita AR, Myers JA, Krochmal L, et al. The safety and efficacy of clindamycin phosphate foam 1% versus clindamycin phosphate topical gel 1% for the treatment of acne vulgaris. J Drugs Dermatol 2005; 4: 48-56.
12. Guay DR. Topical clindamycin in the management of acne vulgaris. Expert Opin Pharmacother 2007; 8: 2625-2664.
13. Mills CM, Hill SA, Marks R. Transdermal nicotine suppresses cutaneous inflammation. Arch Dermatol 1997; 133: 823-825.
14. Shalita AR, Smith JG, Parish LC, et al. Topical nicotinamide compared with clindamycin gel in the treatment of inflammatory acne vulgaris. Int J Dermatol 1995; 34: 434-437.
15. Dos SK, Barbhuiya JN, Jana S, et al. Comparative evaluation of clindamycin phosphate 1% and clindamycin phosphate 1% with nicotinamide gel 4% in the treatment of acne vulgaris. Indian J Dermatol Venereol Leprol 2003; 69: 8-9.
16. Sardesai VR, Kambli VM. Comparison of efficacy of topical clindamycin and nicotinamide combination with plain clindamycin for the treatment of acne vulgaris and acne resistant to topical antibiotics. Indian J Dermatol Venereol Leprol 2003; 69: 138-139.
17. Del Rosso JQ, Schmidt NF. A review of the anti-inflammatory properties of clindamycin in the treatment of acne vulgaris. Cutis 2010; 85: 15-24.
18. Nakase K, Nakaminami H, Noguchi N, et al. First report of high levels of clindamycin-resistant Propionibacterium acnes carrying erm(X) in Japanese patients with acne vulgaris. J Dermatol 2012; 39: 794-796.
19. Luk NM, Hui M, Lee HC, et al. Antibiotic-resistant Propionibacterium acnes among acne patients in a regional skin centre in Hong Kong. J Eur Acad Dermatol Venereol 2011; doi: 10.1111/j.1468-3083.2011.04351.x [Epub ahead of print].
20. González R, Welsh O, Ocampo J, et al. In vitro antimicrobial susceptibility of Propionibacterium acnes isolated from acne patients in northern Mexico. Int J Dermatol 2010; 49: 1003-1007.
21. El-Mahdy TS, Abdalla S, El-Domany R, et al. Detection of a new erm(X)-mediated antibiotic resistance in Egyptian cutaneous propionibacteria. Anaerobe 2010; 16: 376-379.
22. Kinney MA, Yentzer BA, Fleischer AB Jr, et al. Trends in the treatment of acne vulgaris: are measures being taken to avoid antimicrobial resistance? J Drugs Dermatol 2010; 9: 519-524.
23. Burke BM, Cunliffe WJ. The assessment of acne vulgaris - the Leeds technique. Br J Dermatol 1984; 111: 83-92.
24. Youn SW, Kim SJ, Hwang IA, et al. Evaluation of facial skin type by sebum secretion: discrepancies between subjective descriptions and sebum secretion. Skin Res Technol 2002; 8: 168-172.
25. Cook CH, Centner RL, Michaels SE. An acne grading method using photographic standards. Arch Dermatol 1979; 115: 571-575.
26. Morganti P, Berardesca E, Guarneri B, et al. Topical clindamycin 1% vs. linoleic acid-rich phosphatidylcholine and nicotinamide 4% in the treatment of acne: a multicentre-randomized trial. Int J Cosmet Sci 2011; 33: 467-476.
27. Wei B, Pang Y, Zhu H, et al. Dry or normal skin have been proposed as protective factors against development of acne vulgaris. J Eur Acad Dermatol Venereol 2010; 24: 953-957.
28. Grange PA, Raingeaud J, Calvez V, et al. Nicotinamide inhibits Propionibacterium acnes-induced IL-8 production in keratinocytes through the NF-kappaB and MAPK pathways. J Dermatol Sci 2009; 56: 106-112.
29. Pietrzak L, Mogielnicki A, Buczko W. Nicotinamide and its metabolite N-methylnicotinamide increase skin vascular permeability in rats. Clin Exp Dermatol 2009; 34: 380-384.
30. Zouboulis CC. Acne and sebaceous gland function. Clin Dermatol 2004; 22: 360-366.
31. Harper JC, Thiboutot DM. Pathogenesis of acne: recent research advances. Adv Dermatol 2003; 19: 1-10.
32. Knor T. The pathogenesis of acne. Acta Dermatovenereol Croat 2005; 13: 44-49.